Project Details
Description
The funding is an award to Rachel Heilman, a Fellow in Dr. Farrow's lab. The award will be used for project support. Below is information on the presentation:
Title: Inhibition of phosphodiesterase 1C (PDE1C) and phosphodiesterase 5 (PDE5) prevent hyperoxia-induced right ventricular hypertrophy (RVH) in neonatal mice
Heilman, Rachel P MD1, Lagoski, Megan B MD1, Lee, Keng Jin PhD1, Taylor, Joann M BS1, Kim, Gina A BS1, Steinhorn, Robin H MD2, Berkelhamer, Sara K MD1, Farrow, Kathryn N MD, PhD1.
1 Northwestern University, Chicago, IL. 2 University of California Davis, Davis, CA.
Purpose:
The purpose of this study is to determine the role of PDE1C and PDE5 in the right ventricle (RV) and left ventricle (LV) in neonatal mice with pulmonary hypertension (PH) and RVH, after hyperoxia exposure.
Status | Finished |
---|---|
Effective start/end date | 10/1/14 → 9/30/15 |
Funding
- Scientific Therapeutics Information, Inc. (Award 10/16/14)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.